Rafferty Asset Management, LLC Kura Oncology, Inc. Transaction History
Rafferty Asset Management, LLC
- $29.7 Billion
- Q3 2025
A detailed history of Rafferty Asset Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 113,222 shares of KURA stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,222
Previous 105,110
7.72%
Holding current value
$1.27 Million
Previous $606,000
65.35%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding KURA
# of Institutions
214Shares Held
81.2MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...